Marché des implants rachidiens en Asie-Pacifique – Tendances et prévisions du secteur jusqu’en 2031

Analyse et taille du marché des implants rachidiens en Asie-Pacifique

Sur le marché dynamique des implants rachidiens, les avancées récentes incluent l'introduction d'implants en alliage de titane hautement durables, garantissant une longévité et une biocompatibilité améliorées. En outre, une application pionnière intègre des algorithmes d'IA pour la sélection d'implants personnalisés et la planification chirurgicale, marquant un changement de paradigme dans les soins aux patients. Alors que les lésions traumatiques de la moelle épinière (LME) surviennent à un rythme de 40 à 80 cas par million chaque année, ces innovations sont prometteuses pour répondre au risque de mortalité plus élevé auquel sont confrontés les patients atteints de LME, résultant souvent d'incidents liés au travail ou au sport, comme le souligne l'Organisation mondiale de la santé (OMS).                          

Data Bridge Market Research analyse que le marché des implants rachidiens en Asie-Pacifique, qui était de 3,15 milliards USD en 2023, devrait atteindre 4,69 milliards USD d'ici 2031 et devrait connaître un TCAC de 5,1 % au cours de la période de prévision de 2024 à 2031. Cela indique la valeur marchande. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché des implants rachidiens en Asie-Pacifique

Market Definition

Spinal implants, crucial in spinal surgeries, enhance fusion, stability, and correct deformities. Constructed from metals such as stainless steel or titanium, they offer varied sizes and types including hooks, cages, screws, plates, and rods. Ongoing research aims to refine implant efficacy, advancing treatment outcomes in spinal interventions.            

Asia-Pacific Spinal Implants Market Dynamics

Drivers

• Increasing Aging Population Creates Demand

The aging population globally is fueling demand in the spinal implants market due to heightened susceptibility to spinal disorders necessitating surgical remedies. With age-related degenerative changes in the spine becoming more prevalent, older individuals increasingly seek surgical interventions, propelling the market's growth. This demographic trend underscores the significance of spinal implants in addressing age-associated spinal conditions.

• Rising Incidence of Spinal Disorders Leads to Spinal Implants

The surge in spinal disorders such as degenerative disc disease, spinal stenosis, and herniated discs is propelling the demand for spinal implants. As these conditions become more prevalent globally, the necessity for surgical interventions rises, creating a significant market demand for advanced spinal implant technologies to address the diverse needs of patients seeking relief from spinal ailments.

Opportunities

• Patient Preference for Non-Fusion Procedures Spur Innovation

Patients are increasingly favoring non-fusion spinal procedures such as artificial disc replacement and dynamic stabilization due to their potential for maintaining spinal motion and reducing the risk of adjacent segment degeneration. This trend is spurring innovation in the spinal implants market, with manufacturers focusing on developing advanced technologies to meet the growing demand for non-fusion solutions.

• Rising Demand for Patient-Specific Implants

The emergence of 3D printing technology allows for the creation of personalized spinal implants tailored to individual patient anatomy. These implants provide superior fit, enhancing surgical outcomes and reducing the need for revisions. This innovation marks a significant advancement in spinal surgery, promising better patient outcomes through precise, custom-made implant solutions. 

Restraints/Challenges

• Ethical and Legal Considerations in Product Approval

Stringent regulations and lengthy approval processes impede the timely introduction of innovative spinal implant products, prolonging the development cycle and delaying market entry. This hampers manufacturers' ability to address evolving clinical needs efficiently, stifling innovation and limiting patient access to potentially beneficial treatments. Consequently, the market may lag in providing cutting-edge solutions, impacting both patients and industry growth. 

• High Cost of Spinal Implant Surgeries

The high cost of spinal implant surgeries creates barriers to access for patients lacking sufficient insurance coverage or financial resources. This limits market growth as potential patients may postpone or forego treatment, reducing demand for spinal implant products. Consequently, manufacturers may experience decreased sales and revenue, hindering market growth and innovation. 

This Asia-Pacific spinal implants market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific spinal implants market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In August 2022, Nexus Spine launched PressON, their innovative posterior lumbar fixation system. Utilizing rods that press onto pedicle screws instead of traditional set screws, PressON mitigates the risk of loosening, enhancing spinal stabilization in surgical procedures
• In April 2021, NuVasive, Inc. received FDA Approval for NuVasive Simplify Cervical Artificial Disc, expanding their C360 portfolio. This milestone is poised to enhance demand and sales, strengthening company credibility in the market
• In February 2021, Surgeons embraced Medtronic's newly approved Midas Rex and Mazor Robotic guidance system for minimally invasive spinal procedures, marking a significant advancement in spine surgeries. This adoption enhances Medtronic's credibility and revenue potential in the market
• In November 2020, Stryker completed the acquisition of Wright Medical Group N.V., enriching its product portfolio in extremities and biologics globally. This strategic move is anticipated to drive increased sales and demand for Stryker's products in the future

Asia-Pacific Spinal Implants Market Scope

The Asia-Pacific spinal implants market is segmented on the basis of product, materials, application, indication, technology, surgery type, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Fusion Devices
• Non-Fusion Devices
• Spine Biologics
• Spine Bone Growth Stimulators
• Others

Material

• Metals
• Ceramic
• Biomaterial
• Polymers
• Others

 Application

• Cervical
• Thoracic
• Lumber

 Indication

• Spinal Trauma
• Deformity

 Technology

• Fusion
• Spine Biologics
• VCF
• Decompression
• Motion Preservation
• Others

 Surgery Type

• Open Surgeries
• Minimally Invasive Surgeries

 End User

• Hospitals
• Specialty Clinics
• Spine Centers
• Trauma Centers
• Ambulatory Surgical Centers (ASCs)
• Others

Distribution Channel

• Direct Tender
• Retail Sales

Asia-Pacific Spinal Implants Market Regional Analysis/Insights

The Asia-Pacific spinal implants market is analysed and market size insights and trends are provided by country, product, materials, application, indication, technology, surgery type, end user and distribution channel as referenced above.

The countries covered in the Asia-Pacific spinal implants market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)

China is dominating in the Asia-Pacific spinal implants market due to the increased geriatric population and technological advancement in the country.

Japan is dominating in the Asia-Pacific spinal implants market with the second highest market share as the demand for spinal implants in the healthcare sector in the country and worldwide is increasing.

India is dominating in the Asia-Pacific spinal implants market with the third highest market share owing to the increased risk of spinal disorders and deformities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

Le marché des implants rachidiens de la région Asie-Pacifique vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les équipements en capital, la base installée de différents types de produits pour le marché des implants rachidiens de la région Asie-Pacifique, l'impact de la technologie utilisant les courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché des implants rachidiens de la région Asie-Pacifique. Les données sont disponibles pour la période historique 2016-2021.

Analyse du paysage concurrentiel et des parts de marché des implants rachidiens en Asie-Pacifique

Le paysage concurrentiel du marché des implants rachidiens en Asie-Pacifique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liées au marché des implants rachidiens en Asie-Pacifique.

Certains des principaux acteurs opérant sur le marché des implants rachidiens en Asie-Pacifique sont :

• Medtronic (États-Unis)
• Canwell Medical Co., Ltd. (Chine)
• NuVasive, Inc. (États-Unis)
• SeaSpine (États-Unis)
• Globus Medical (États-Unis)
• RTI Surgical (États-Unis)
• MW Industries (États-Unis)
• Captiva Spine, Inc. (États-Unis)
• XTANT MEDICAL (États-Unis)
• SINTX Technologies, Inc. (États-Unis)
• Orthofix Medical, Inc. (États-Unis)
• Alphatec Spine, Inc. (États-Unis)
• Wenzel Spine (États-Unis)
• Johnson & Johnson Services, Inc. (États-Unis)
• Tecomet, Inc. (États-Unis)
• Stryker (États-Unis)
• Zimmer Biomet (États-Unis)

SKU-1958